Cargando…
Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with esophageal cancer
Metabolomics has been reported as an efficient tool to screen biomarkers that are related to esophageal cancer. However, the metabolic biomarkers identifying malignant degrees and therapeutic efficacy are still largely unknown in the disease. Here, GC-MS-based metabolomics was used to understand met...
Autores principales: | Yang, Xiao-li, Wang, Peng, Ye, Hua, Jiang, Ming, Su, Yu-bin, Peng, Xuan-xian, Li, Hui, Zhang, Jian-ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9513043/ https://www.ncbi.nlm.nih.gov/pubmed/36176418 http://dx.doi.org/10.3389/fonc.2022.938234 |
Ejemplares similares
-
Serum Metabolic Profiling Analysis of Chronic Gastritis and Gastric Cancer by Untargeted Metabolomics
por: Yu, Lin, et al.
Publicado: (2021) -
Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022) -
Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians
por: Wang, Zongyi, et al.
Publicado: (2022) -
(1)H NMR-based metabolomics of paired tissue, serum and urine samples reveals an optimized panel of biofluids metabolic biomarkers for esophageal cancer
por: Ouyang, Ting, et al.
Publicado: (2023) -
Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers
por: Zhu, Zi-Jia, et al.
Publicado: (2020)